UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043418
Receipt number R000049572
Scientific Title Japanese Translation and Validation of the Lindop Parkinson's Physiotherapy Assessment Scale (LPA) in Patients with Parkinson's Disease
Date of disclosure of the study information 2021/02/22
Last modified on 2024/01/10 14:46:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Japanese Translation and Validation of the Lindop Parkinson's Physiotherapy Assessment Scale (LPA) in Patients with Parkinson's Disease

Acronym

Japanese Translation and Validation of the LPA

Scientific Title

Japanese Translation and Validation of the Lindop Parkinson's Physiotherapy Assessment Scale (LPA) in Patients with Parkinson's Disease

Scientific Title:Acronym

Japanese Translation and Validation of the LPA

Region

Japan


Condition

Condition

Parkinson's Disease

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Patients with Parkinson's disease have the most difficulty in getting up from bed in activities of daily living. However, there is no specialized measurement tool for evaluating the bed mobility that is the target of rehabilitation for patients with Parkinson's disease.
Therefore, we develop in the basic motor function of Parkinson's disease called "Lindop Parkinson's Physiotherapy Assessment Scale (abbreviated as LPA)" developed for medical staff in recent years. There is an evaluation method that has been verified, its reliability, validity, and reactivity have been verified, and it is already widely used internationally.
LPA is a battery that specializes in evaluating the two basic movements of Parkinson's disease patients (bed movement: 4 items, walking: 6 items). Scores are given to each item in 4 stages (0 to 3 points), and the higher the score, the higher the degree of independence.
The purpose of this study is to develop Japanese version of LPA, then confirm the validity and reliability of the Japanese version of the LPA.

Basic objectives2

Others

Basic objectives -Others

To confirm the reliability and validity.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Gait (6items), Bed mobility (4items) from LPA

Key secondary outcomes

MDS-UPDRS motor, MMSE.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

99 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients with idiopathic PD (Hoehn & Yahr stage I-IV) who are able to sit down/ stand up from a chair, walk, and get in/out of bed were enrolled in this study.
We recruited in-patients at Osaka University Hospital, Osaka, Japan.

Key exclusion criteria

Patients could be excluded if they had history of other neurologic or musculoskeletal disorders, severe orthopedic disease and pain that affected their strategies for sitting down/ standing up from a chair, gait, and getting in/out of bed.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Seira
Middle name
Last name Taniguchi

Organization

Graduate School of Medicine Faculty of Medicine, Osaka University

Division name

Department of Neurology

Zip code

565-0871

Address

Yamadaoka2-2, Suita-city, Osaka

TEL

05055321220

Email

m-pas@umin.ac.jp


Public contact

Name of contact person

1st name Seira
Middle name
Last name Taniguchi

Organization

Graduate School of Medicine Faculty of Medicine, Osaka University

Division name

Department of Neurology

Zip code

565-0871

Address

Yamadaoka2-2, Suita-city, Osaka

TEL

050-5532-1224

Homepage URL


Email

m-pas@umin.ac.jp


Sponsor or person

Institute

Graduate School of Medicine Faculty of Medicine, Osaka University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Graduate School of Medicine Faculty of Medicine, Osaka University

Address

Yamadaoka2-2, Suita-city, Osaka

Tel

06-6877-5111

Email

rinri#hp-crc.med.osaka-u.ac.jp (please replace # into @)


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 02 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 02 Month 22 Day

Date of IRB

2022 Year 12 Month 05 Day

Anticipated trial start date

2023 Year 01 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The Japanese version of the LPA was translated with the permission of the developer, Fiona Lindop (University Hospitals of Derby & Burton NHS Foundation Trust). This study has been approved by the research ethics committee at Osaka University Hospital.


Management information

Registered date

2021 Year 02 Month 22 Day

Last modified on

2024 Year 01 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049572


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name